Haleon Pakistan Limited (PSX:HALEON)
762.15
-16.78 (-2.15%)
At close: May 13, 2026
Haleon Pakistan Company Description
Haleon Pakistan Limited engages in the manufacture, marketing, and sale of pharmaceutical and consumer healthcare products in Pakistan, the Philippines, and Qatar.
The company offers oral health, pain relief, wellness and nutrition, and respiratory health products.
It sells its products primarily under the Panadol, CaC-1000 Plus, Sensodyne, paradontax, T-Day, ENO, Hydrozole, Qalsium-D, and Voltral Emulgel brands.
The company was formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited and changed its name to Haleon Pakistan Limited in January 2023.
Haleon Pakistan Limited was incorporated in 2015 and is headquartered in Karachi, Pakistan. Haleon Pakistan Limited is a subsidiary of Glaxosmithkline Consumer Healthcare B.V.
Haleon Pakistan Limited
| Country | Pakistan |
| Founded | 2015 |
| Industry | Pharmaceutical Preparations |
| Employees | 451 |
| CEO | Qawi Naseer |
Contact Details
Address: 11-A, Sky Tower (East Wing) Karachi, 75600 Pakistan | |
| Phone | 92 21 111 425 366 |
| Website | haleon.pk |
Stock Details
| Ticker Symbol | HALEON |
| Exchange | Pakistan Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | PKR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Qawi Naseer | Chief Executive Officer |
| Babar Sharif | Chief Financial Officer |